A causal link between autoantibodies and neurological symptoms in long COVID
In a paper from the Dr. Akiko Iwasaki lab at Yale they wrote "the use of blood products ...from people with LC in treatment settings requires careful consideration, as they may pose pathologic risks to the recipients".